Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal

Neuropsychopharmacology

Volumn 16, Issue 2, 1997, Pages 174-182

  Wang, Gene Jack ^a,b   Volkow, Nora D ^a,b   Fowler, Joanna S ^a   Logan, Jean ^a   Abumrad, Naji N ^d   Hitzemann, Robert J ^b,c   Pappas, Naomi S ^a   Pascani, Kathy ^c  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

naloxone; opiate abuse; PET, withdrawal

Indexed keywords

DIAMORPHINE; DOPAMINE 2 RECEPTOR; METHADONE; NALOXONE; OPIATE; RACLOPRIDE; NARCOTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG WITHDRAWAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; ADDICTION; BASAL GANGLION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; METABOLISM; MIDDLE AGED; PSYCHOLOGICAL ASPECT; SCINTISCANNING; WITHDRAWAL SYNDROME;

ADULT; BASAL GANGLIA; HUMANS; MALE; MIDDLE AGED; NALOXONE; NARCOTICS; RECEPTORS, DOPAMINE D2; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031060799     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(96)00184-4     Document Type: Article

References (32)

1. Acquas E. Carboni E, Di Chiara G (1991): Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats. Eur J Pharmacol 193:133
2. Ary M, Cox B, Lomax P (1977): Dopaminergic mechanisms in precipitated withdrawal in morphine-dependent rats. J Pharmacol Exp Therap 200:271-276
3. Brodie MS, Dunwiddie TV (1990): Cocaine effects in the ventral tegmental area: Evidence for an indirect dopaminergic mechanism of action. Naunyn-Schmiedeberg's Arch Pharmacol 342:660-665
4. Blum K, Cull JG, Braverman ER, Comings DE (1996): Reward deficiency syndrome. Am Scientist 84:132-145
5. 11C]raclopride is altered by drugs that modify synaptic dopamine levels. Synapse 13:350-356
6. Farde L, Ehrin E, Eriksson L, Greitz T, Hall H, Hedström C-G, Litton JE, Sedvall G (1985): Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proc Natl Acad Sci USA 82:3863-3867
7. Ferrari F, Baggio G (1982): Influence of lisuride on morphine withdrawal signs in the rat: A dopamine-mimetic effect. Psychopharmacology 78:326-330
8. Gomaa AA, Mohamed LH, Ahmed HN (1989): Modification of morphine-induced analgesia, tolerance and dependence by bromocriptine. Eur J Pharmacol 170:129-135
9. Gunne LM (1965): Some pharmacological agents modifying the morphine abstinence in dogs. Arch Int Pharacodyn Ther 157:293-298
10. 2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature 371:155-157
11. 2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology 116:285-290
12. Hurd YL, Ungerstedt U (1989): Cocaine: An in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum. Synapse 3:48-54
13. Kanof PD, Handelsman L, Aronson MJ, Ness R, Cochrane KJ, Rubinstein KJ (1992): Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects. J Pharmacol Exper Ther 260:355-363
14. Koob GF, Bloom FE (1988): Cellular and molecular mechanisms of drug dependence. Science 242:715-723
15. Lal H, Numan R (1976): Blockade of morphine-withdrawal body shakes by haloperidol. Life Sci 18:163-168
16. Lal H, Puri SK, Karkalas Y (1971): Blockade of opioid withdrawal symptoms by haloperidol in rats and humans. Pharmacologist 13:263
17. Levinson I, Galynker II, Rosenthal RN (1995): Methadone withdrawal psychosis. J Clin Psychiatry 56:73-76
18. 11C]methyl-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10:740-747
19. Pothos E, Rada P, Mark GP, Hoebel BG (1991): Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res 566:348-350
20. Rossetti ZL, Melis F, Carboni S, Gessa GL (1990): Dopamine release in tolerance and withdrawal from morphine or ethanol. Neurosci Lett 39:S184
21. Rossetti ZL, Hmaidan Y, Gessa GL (1992): Marked inhibition of mesolimbic dopamine release: A common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmac 221:227-231
22. 3H]raclopride: Implications for positron emission tomography of the human brain. Synapse 3:96-97
23. 11C]raclopride. Soc Neurosci Abs 19:302
24. Tanganelli S, Antonelli T, Morari M, Bianchi C, Beani L (1991): Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. Neurosci Lett 122:270-272
25. Uhl GR, Elmer GI, LaBuda MC, Pickens RW (1995): Genetic Influences in Drug Abuse. In Bloom FE, Kupfer DJ (eds), Psychopharmacology: The Fourth Generation of Progress. New York, Raven Press, pp 1793-1806
26. Volkow ND, Fowler JS, Wolf AP, Schlyer DJ, Shiue C-Y, Alpert R, Dewey SL, Logan J, Bendriem B, Christman DR, Hitzemann RJ, Henn F (1990): Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry 147:719-724
27. 2 receptor availability is associated with reduced frontal metabolism in cocaine abuser. Synapse 14:169-177
28. 11C]raclopride binding in the human brain. J Nucl Med 34:609-613
29. 11C]raclopride in the human brain. Synapse 16:255-262
30. Volkow ND, Wang G-J, Fowler JS, Logan J, Ding Y-S, Gatley SJ, Hitzemann R, Pappas N. (1996): Decreases in dopamine receptors but not in dopamine transporters in alcoholics. J Nucl Med 37:33
31. 2 receptors. J Comput Assist Tomogr 20:423-428
32. Yoshimoto K, McBride WJ, Lumeng L, Li TK (1992): Ethanol enhances the release of dopamine and serotonin in the nucleus accumbens of HAD and LAD lines of rats. Alcoholism: Clin Exper Res 16:781-785.